Today: 8 June 2026
Browse Category

HKG:3690.HK 28 July 2025 - 27 November 2025

Meituan Class B Stock Today (27 November 2025): Price Pullback, AI Leadership Shake‑Up and Q3 Earnings Countdown

Meituan Class B Stock Today (27 November 2025): Price Pullback, AI Leadership Shake‑Up and Q3 Earnings Countdown

Meituan Class B shares closed at HK$102.6 on Thursday, down about 1.1% after a strong rally the previous day. Investors digested news that Wang Huiwen, co-founder and head of Meituan’s AI arm Lightyear Away, has stepped down from key roles. Markets await Q3 results Friday, with analysts expecting a swing to heavy loss amid ongoing price wars.
27 November 2025
··
Meituan (3690.HK) Soars to HK$100: Food-Delivery Wars, AI Ambitions & What Analysts Expect

Meituan (3690.HK) Soars to HK$100: Food-Delivery Wars, AI Ambitions & What Analysts Expect

Meituan shares closed at HK$100.00 on Oct 23, up 4.06% for the day after rebounding from a 52-week low of HK$94.05 last week. The company reported an 89% profit drop in Q2 2025 amid price wars but is expanding overseas and investing heavily in AI. Meituan leads China’s food delivery market with about 70% share. Analysts set a 12-month target of HK$119.7, citing both tech investments and ongoing subsidy battles.
23 October 2025
···
From Skies to Sidewalks: Inside the 2025 Drone Delivery Revolution

From Skies to Sidewalks: Inside the 2025 Drone Delivery Revolution

UPS Flight Forward completed the first true BVLOS drone deliveries in the U.S. without human observers in November 2024, monitored remotely from Kentucky. Amazon, Wing, and Zipline expanded drone and robot delivery pilots in the U.S. and abroad. The FAA and EU regulators advanced new rules to enable broader drone operations. China’s Meituan and Europe’s Manna Aero ramped up commercial drone deliveries in 2024–2025.
28 July 2025
·······

Stock Market Today

  • KOSPI Index Plunges Amid Global Market Turmoil
    June 8, 2026, 9:07 AM EDT. South Korea's KOSPI experienced a sharp crash triggered by margin stress in chip stocks and a circuit breaker trading halt. The selloff in global markets was fueled by a strong U.S. jobs report signaling prolonged high interest rates, fears of a yen carry trade unwind amid Bank of Japan tightening, and a crypto selloff following Zcash network vulnerabilities. U.S. futures rebounded slightly as chip stocks recovered, with investors focused on upcoming inflation data and SpaceX's anticipated IPO. Rising Middle East tensions keep oil prices elevated near $94 per barrel. The volatile market reflects growing concerns over liquidity absorption from the SpaceX listing, geopolitical risks, and tightening monetary policies globally.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Go toTop